{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:05:04Z","timestamp":1794841504037,"version":"4.9.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T00:00:00Z","timestamp":1414368000000},"content-version":"vor","delay-in-days":209,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.euroneuro.2013.10.008","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T06:16:43Z","timestamp":1382509003000},"page":"608-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":282,"title":["The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain"],"prefix":"10.1016","volume":"24","author":[{"given":"A.-L.","family":"Klauke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Racz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.10.008_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/138955709787001785","article-title":"Cannabinoid type 2 receptor as a target for chronic-pain","volume":"9","author":"Beltramo","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib3","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1460-9568.2006.04684.x","article-title":"CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms","volume":"23","author":"Beltramo","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","article-title":"Cannabinoids in medicine: a review of their therapeutic potential","volume":"105","author":"Ben Amar","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib5","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1523\/JNEUROSCI.4814-06.2007","article-title":"Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis","volume":"27","author":"Benito","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","article-title":"Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPAR\u03b3 pathway","volume":"178","author":"Bento","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1515\/znc-2010-9-1009","article-title":"Antibacterial activity of the essential oil from Rosmarinus officinalis and its major components against oral pathogens","volume":"65","author":"Bernardes","year":"2010","journal-title":"Z. Naturforsch. C: J. Biosci."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/10408440802014287","article-title":"Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications","volume":"38","author":"Calabrese","year":"2008","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib11","first-page":"1","article-title":"The antioxidant effect of \u03b2-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation","volume":"1","author":"Calleja","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0304-3959(01)00454-7","article-title":"CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain","volume":"96","author":"Clayton","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib14","series-title":"Wall and Melzack's Textbook of Pain","first-page":"905","article-title":"Response to nerve injury in relation to neuropathic pain","author":"Devor","year":"2006"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib15","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pnpbp.2012.04.012","article-title":"The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, \u03b2-caryophyllene, in male mice","volume":"38","author":"Galdino","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib17","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1476-5381.2010.00745.x","article-title":"Phytocannabinoids beyond the Cannabis plant\u2014do they exist?","volume":"160","author":"Gertsch","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0014-827X(01)01092-8","article-title":"Local anaesthetic activity of beta-caryophyllene","volume":"56","author":"Ghelardini","year":"2001","journal-title":"Farmaco"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejpain.2008.03.014","article-title":"Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain","volume":"13","author":"Hald","year":"2009","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/08820139.2013.764317","article-title":"Inflammatory processes in complex regional pain syndromes","volume":"42","author":"Hauser","year":"2013","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0306-4522(98)00524-7","article-title":"Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study","volume":"90","author":"Hohmann","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1124\/jpet.103.060079","article-title":"Selective activation of cannabinoid CB 2 receptors suppresses hyperalgesia evoked by intradermal capsaicin","volume":"308","author":"Hohmann","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib25","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.freeradbiomed.2012.01.014","article-title":"\u03b2-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner","volume":"52","author":"Horv\u00e1th","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0731-7085(02)00119-X","article-title":"GC\/MS evaluation of thyme (Thymus vulgaris L.) oil composition and variations during the vegetative cycle","volume":"29","author":"Hudaib","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib27","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1185\/030079906X158066","article-title":"Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain","volume":"23","author":"Iskedjian","year":"2007","journal-title":"Curr. Med. Res. Opinions"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib29","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1021\/jf034169i","article-title":"Volatile constituents from Cinnamomum zeylanicum fruit stalks and their antioxidant activities","volume":"51","author":"Jayaprakasha","year":"2003","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/j.1532-2149.2012.00242.x","article-title":"Involvement of peripheral cannabinoid and opioid receptors in beta-caryophyllene-induced antinociception","volume":"17","author":"Katsuyama","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2010.09.004","article-title":"The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects","volume":"60","author":"Kinsey","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib32","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1211\/jpp.59.12.0005","article-title":"Potentiating effect of \u03b2-caryophyllene on anticancer activity of \u03b1-humulene, isocaryophyllene and paclitaxel","volume":"59","author":"Legault","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib33","first-page":"402","volume":"25","author":"Livak","year":"2001","journal-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1365-2184.2008.00561.x","article-title":"Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells","volume":"41","author":"Loizzo","year":"2008","journal-title":"Cell Proliferation"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2009.09.021","article-title":"1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice","volume":"37","author":"Luongo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib37","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","article-title":"Modulation of the cannabinoid CB 2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0031-9422(00)00474-X","article-title":"The essential oil of Origanum vulgare L. ssp. vulgare growing wild in Vilnius district (Lithuania)","volume":"57","author":"Mockute","year":"2001","journal-title":"Phytochemistry"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3959(03)00163-5","article-title":"The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions","volume":"105","author":"Naef","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib42","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1021\/jf030635s","article-title":"Effect of storage on the essential oil composition of Piper nigrum L. fruits of different ripening states","volume":"52","author":"Orav","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1447-0756.2011.01802.x","article-title":"Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial","volume":"38","author":"Ou","year":"2012","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib44","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1523\/JNEUROSCI.3400-08.2008","article-title":"Crucial role of CB2 cannabinoid receptor in the regulation of central immune responses during neuropathic pain","volume":"28","author":"Racz","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pbb.2011.02.024","article-title":"Pharmacological characterization of AM1710, a putative cannabinoid CB 2 agonist from the cannabilactone class: antinociception without central nervous system side-effects","volume":"98","author":"Rahn","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib47","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib48","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib49","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/jpet.105.089474","article-title":"Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors","volume":"315","author":"Shoemaker","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0091-3057(97)00422-X","article-title":"Biphasic effects of anandamide","volume":"59","author":"Sulcova","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neuint.2003.06.002","article-title":"Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain","volume":"45","author":"Tanga","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuron.2007.07.016","article-title":"Nociceptors\u2014noxious stimulus detectors","volume":"55","author":"Woolf","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.10.008_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2008.01.010","article-title":"Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain","volume":"583","author":"Yamamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib54","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/np50085a029","article-title":"Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents","volume":"55","author":"Zheng","year":"1992","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.euroneuro.2013.10.008_bib55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/363215a0","article-title":"Early medical use of cannabis","volume":"363","author":"Zias","year":"1993","journal-title":"Nature"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13003027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13003027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T11:23:04Z","timestamp":1539256984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13003027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0924977X13003027"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.10.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP.","name":"copyright","label":"Copyright"}]}}